DNA X Inc
SONM
17 hedge funds and large institutions have $8.04M invested in DNA X Inc in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 10 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
26% less funds holding
Funds holding: 23 → 17 (-6)
54% less capital invested
Capital invested by funds: $17.3M → $8.04M (-$9.28M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$824K |
| 2 |
VF
Virtu Financial
New York
|
+$60.9K |
| 3 |
State Street
Boston,
Massachusetts
|
+$43.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$26.1K |
| 5 |
Morgan Stanley
New York
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.49M |
| 2 |
HP
Harvey Partners
Tarrytown,
New York
|
-$1.25M |
| 3 |
Renaissance Technologies
New York
|
-$1.16M |
| 4 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$1.14M |
| 5 |
USPCM
Union Square Park Capital Management
New York
|
-$820K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| – | -$9K | -6 | Closed |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -3 | Closed |
|
SONM Hedge Fund Activity: Q2 2021 in Review
17 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q2 2021, worth a combined $8.04M — down 54% from $17.3M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SONM and 4 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $824K. The largest seller was Perkins Capital Management, exiting entirely with an estimated $1.49M sold.
- 17 institutional investors held DNA X Inc (SONM) as of Q2 2021, down from 23 in Q1 2021.
- Funds reported $8.04M of DNA X Inc stock for Q2 2021, down 54% quarter-over-quarter.
- 4 funds opened new DNA X Inc positions in Q2 2021 and 10 closed out, a net change of -6 holders.
- The largest DNA X Inc buyer in Q2 2021 was Vanguard Group, an estimated $824K added.
- The largest DNA X Inc seller in Q2 2021 was Perkins Capital Management, an estimated $1.49M sold.
Based on aggregated 13F filings for Q2 2021.